In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions.
D000107:Acetylation; D000123:Acetyltransferases / Q000378:metabolism; D002460:Cell Line; D002467:Cell Nucleus / Q000378:metabolism; D002478:Cells, Cultured; D002843:Chromatin / Q000737:chemistry* / Q000378:metabolism; D003920:Diabetes Mellitus / Q000378:metabolism*; D005947:Glucose / Q000378:metabolism; D051548:Histone Acetyltransferases; D006655:Histone Deacetylases / Q000737:chemistry; D006657:Histones / Q000737:chemistry; D006801:Humans; D007249:Inflammation; D008156:Luciferases / Q000378:metabolism; D008239:Lysine / Q000737:chemistry; D009000:Monocytes / Q000378:metabolism; D016328:NF-kappa B / Q000378:metabolism; D011233:Precipitin Tests; D011401:Promoter Regions, Genetic; D011485:Protein Binding; D020033:Protein Isoforms; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013997:Time Factors; D014158:Transcription, Genetic; D014162:Transfection; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D002843:Chromatin; D006657:Histones; D016328:NF-kappa B; D020033:Protein Isoforms; D014409:Tumor Necrosis Factor-alpha; D008156:Luciferases; D000123:Acetyltransferases; D051548:Histone Acetyltransferases; D006655:Histone Deacetylases; D005947:Glucose; D008239:Lysine